Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization

Acta Biomaterialia

Volumn 30, Issue , 2016, Pages 49-61

  Steinbach, Jill M ^a   Seo, Young Eun ^a   Saltzman, W Mark ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Cell penetrating peptides; Drug delivery; Gene delivery; Nanoparticle

Indexed keywords

CONTROLLED DRUG DELIVERY; CYTOLOGY; GENE TRANSFER; GLYCOPROTEINS; PEPTIDES; SURFACE CHEMISTRY; SURFACE TREATMENT; TARGETED DRUG DELIVERY;

CELL INTERNALIZATION; CELL-BINDING; CELL-PENETRATING PEPTIDE; GENE DELIVERY; INTRACELLULAR DELIVERY; PLGA NANOPARTICLES; POLY LACTIC-CO-GLYCOLIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); SURFACE LIGANDS; SURFACE-MODIFICATION;

NANOPARTICLES;

AVIDIN; CELL PENETRATING PEPTIDE; NANOPARTICLE; POLYGLACTIN; POLYGLACTIN NANOPARTICLE; UNCLASSIFIED DRUG; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CELL ADHESION; CELL DENSITY; CELL TRANSPORT; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL LINE; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; PARTICLE SIZE; PINOCYTOSIS; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; TEMPERATURE DEPENDENCE; ZETA POTENTIAL; CHEMISTRY;

CELL-PENETRATING PEPTIDES; HELA CELLS; HUMANS; LACTIC ACID; NANOPARTICLES; POLYGLYCOLIC ACID;

EID: 84951568992     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.11.029     Document Type: Article

References (102)

1. C.J. Cheng, and W.M. Saltzman Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides Biomaterials 32 2011 6194 6203
2. W. Gao, Z. Xiao, A. Radovic-Moreno, J. Shi, R. Langer, and O.C. Farokhzad Progress in siRNA delivery using multifunctional nanoparticles Methods Mol. Biol. 629 2010 53 67
3. J.M. Steinbach, C.E. Weller, C.J. Booth, and W.M. Saltzman Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection J. Controlled Release 162 2012 102 110
4. K.A. Woodrow, Y. Cu, C.J. Booth, J.K. Saucier-Sawyer, M.J. Wood, and W.M. Saltzman Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat. Mater. 8 2009 526 533
5. S. Kobsa, and W.M. Saltzman Bioengineering approaches to controlled protein delivery Pediatr. Res. 63 2008 513 519
6. R.F. Pagels, and R.K. Prud'homme Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics J. Controlled Release 219 2015 519 535
7. N. Skalko-Basnet Biologics: the role of delivery systems in improved therapy Biologics 8 2014 107 114
8. J.M. Steinbach Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs Cell. Mol. Life Sci. 72 2015 469 503
9. M. Singh, and M. Salnikova Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies 2014 Academic Press
10. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Preat PLGA-based nanoparticles: an overview of biomedical applications J. Controlled Release 161 2012 505 522
11. R. Dinarvand, N. Sepehri, S. Manoochehri, H. Rouhani, and F. Atyabi Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents Int. J. Nanomed. 6 2011 877 895
12. C.J. Cheng, and W.M. Saltzman Nanomedicine: downsizing tumour therapeutics Nat. Nanotechnol. 7 2012 346 347
13. C.J. Cheng, G.T. Tietjen, J.K. Saucier-Sawyer, and W.M. Saltzman A holistic approach to targeting disease with polymeric nanoparticles Nat. Rev. Drug Discovery 14 2015 239 247
14. I. Bala, S. Hariharan, and M.N.V.R. Kumar PLGA nanoparticles in drug delivery: the state of the art Crit. Rev. Ther. Drug Carrier Syst. 21 2004 387 422
15. L. Brannon-Peppas Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery Int. J. Pharm. 116 1995 1 9
16. H.K. Makadia, and S.J. Siegel Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier Polymers 3 2011 1377 1397
17. M.S. Shive, and J.M. Anderson Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Delivery Rev. 28 1997 5 24
18. W.M. Saltzman Drug Delivery 2001 Oxford New York
19. G. Schliecker, C. Schmidt, S. Fuchs, and T. Kissel Characterization of a homologous series of D, L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro Biomaterials 24 2003 3835 3844
20. T.G. Park Degradation of poly(D, L-lactic acid) microspheres - Effect of molecular-weight J. Controlled Release 30 1994 161 173
21. D.K. Gilding, and A.M. Reed Biodegradable polymers for use in surgery - polyglycolic/poly (lactic acid) homo- and copolymers: 1 Polymer 20 1979 1459 1464
22. Degradable Polymers: Principles and Applications 2 ed. 2002 Springer Science and Business Media
23. D.T. Martin, J.M. Steinbach, J. Liu, S. Shimizu, H.Z. Kaimakliotis, M.A. Wheeler, and et al. Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer Mol. Cancer Ther. 13 2014 71 81
24. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610
25. J.M. Williford, J. Wu, Y. Ren, M.M. Archang, K.W. Leong, and H.Q. Mao Recent advances in nanoparticle-mediated siRNA delivery Annu. Rev. Biomed. Eng. 16 2014 347 370
26. K. Gavrilov, and W.M. Saltzman Therapeutic siRNA: principles, challenges, and strategies Yale J Biol. Med. 85 2012 187 200
27. R. Kanasty, J.R. Dorkin, A. Vegas, and D. Anderson Delivery materials for siRNA therapeutics Nat. Mater. 12 2013 967 977
28. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
29. I.A. Khalil, K. Kogure, H. Akita, and H. Harashima Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 58 2006 32 45
30. A. Hocherl, M. Dass, K. Landfester, V. Mailander, and A. Musyanovych Competitive cellular uptake of nanoparticles made from polystyrene, poly(methyl methacrylate), and polylactide Macromol. Biosci. 12 2012 454 464
31. T. Iversen, T. Skotland, and K. Sandvig Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies Nano Today 6 2011 176 185
32. R. Vacha, F.J. Martinez-Veracoechea, and D. Frenkel Receptor-mediated endocytosis of nanoparticles of various shapes Nano Lett. 11 2011 5391 5395
33. O. Harush-Frenkel, E. Rozentur, S. Benita, and Y. Altschuler Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells Biomacromolecules 9 2008 435 443
34. T. dos Santos, J. Varela, I. Lynch, A. Salvati, and K.A. Dawson Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines Small 7 2011 3341 3349
35. F. Mussbach, M. Franke, A. Zoch, B. Schaefer, and S. Reissmann Transduction of peptides and proteins into live cells by cell penetrating peptides J. Cell. Biochem. 112 2011 3824 3833
36. B.R. Meade, and S.F. Dowdy Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides Adv. Drug Delivery Rev. 59 2007 134 140
37. B.R. Meade, and S.F. Dowdy Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides Adv. Drug Delivery Rev. 60 2008 530 536
38. E. Koren, and V.P. Torchilin Cell-penetrating peptides: breaking through to the other side Trends Mol. Med. 18 2012 385 393
39. T. Lehto, K. Kurrikoff, and U. Langel Cell-penetrating peptides for the delivery of nucleic acids Expert Opin. Drug Deliv. 9 2012 823 836
40. H. Margus, K. Padari, and M. Pooga Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery Mol. Ther. 20 2012 525 533
41. M.C. Morris, S. Deshayes, F. Heitz, and G. Divita Cell-penetrating peptides: from molecular mechanisms to therapeutics Biol. Cell 100 2008 201 217
42. A. Erazo-Oliveras, N. Muthukrishnan, R. Baker, T. Wang, and J.P. Pellois Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges Pharmaceuticals 5 2012 1177 1209
43. F. Madani, S. Lindberg, U. Langel, S. Futaki, and A. Graslund Mechanisms of cellular uptake of cell-penetrating peptides J. Biophys. 2011 2011 414729
44. N.M. Zaki, and N. Tirelli Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting Expert Opin. Drug Deliv. 7 2010 895 913
45. A. Rydstrom, S. Deshayes, K. Konate, L. Crombez, K. Padari, H. Boukhaddaoui, and et al. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles PLoS One 6 2011 e25924
46. J. Wang, Z. Lu, M.G. Wientjes, and J.L. Au Delivery of siRNA therapeutics: barriers and carriers AAPS J. 12 2010 492 503
47. Y.L. Chiu, A. Ali, C.Y. Chu, H. Cao, and T.M. Rana Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells Chem. Biol. 11 2004 1165 1175
48. H. Katas, S. Chen, A.A. Osamuyimen, E. Cevher, and H. Oya Alpar Effect of preparative variables on small interfering RNA loaded Poly(D, L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method J. Microencapsulation 25 2008 541 548
49. N. Nafee, S. Taetz, M. Schneider, U.F. Schaefer, and C.M. Lehr Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides Nanomedicine 3 2007 173 183
50. J. Zhou, T.R. Patel, M. Fu, J.P. Bertram, and W.M. Saltzman Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors Biomaterials 33 2012 583 591
51. T.M. Fahmy, R.M. Samstein, C.C. Harness, and W.M. Saltzman Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting Biomaterials 26 2005 5727 5736
52. C.J. Cheng, R. Bahal, I.A. Babar, Z. Pincus, F. Barrera, C. Liu, and et al. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment Nature 518 2015 107 110
53. Y. Cu, C.J. Booth, and W.M. Saltzman In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery J. Controlled Release 156 2011 258 264
54. Y. Cu, C. LeMoellic, M.J. Caplan, and W.M. Saltzman Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency Nanomedicine 6 2010 334 343
55. Y. Cu, and W.M. Saltzman Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus Mol. Pharm. 6 2009 173 181
56. J. Park, P.M. Fong, J. Lu, K.S. Russell, C.J. Booth, W.M. Saltzman, and et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin Nanomedicine 5 2009 410 418
57. J. Park, T. Mattessich, S.M. Jay, A. Agawu, W.M. Saltzman, and T.M. Fahmy Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates J. Controlled Release 156 2011 109 115
58. S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener, and K. Ballmer-Hofer Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans J. Biol. Chem. 278 2003 35109 35114
59. P. Lundberg, S. El-Andaloussi, T. Sutlu, H. Johansson, and U. Langel Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 21 2007 2664 2671
60. F. Simeoni, M.C. Morris, F. Heitz, and G. Divita Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res. 31 2003 2717 2724
61. T.M. Fahmy, R.M. Samstein, C.C. Harness, and W. Mark Saltzman Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting Biomaterials 26 2005 5727 5736
62. M. Benfer, and T. Kissel Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles Eur. J. Pharm. Biopharm. 80 2012 247 256
63. T. dos Santos, J. Varela, I. Lynch, A. Salvati, and K.A. Dawson Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines PLoS One 6 2011 e24438
64. M. Gotte, D.D. Sofeu Feugaing, and H. Kresse Biglycan is internalized via a chlorpromazine-sensitive route Cell. Mol. Biol. Lett. 9 2004 475 481
65. A.I. Ivanov Pharmacological inhibition of endocytic pathways: is it specific enough to be useful A.I. Ivanov, Methods in Molecular Biology 2008 Humana Press NJ
66. Y. Chen, S. Wang, X. Lu, H. Zhang, Y. Fu, and Y. Luo Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways Blood 117 2011 6392 6403
67. M.G. Qaddoumi, H.J. Gukasyan, J. Davda, V. Labhasetwar, K.J. Kim, and V.H. Lee Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis Mol. Vis. 9 2003 559 568
68. S.E. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and et al. The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U.S.A. 105 2008 11613 11618
69. N. Araki, T. Hatae, A. Furukawa, and J.A. Swanson Phosphoinositide-3-kinase-independent contractile activities associated with Fc gamma-receptor-mediated phagocytosis and macropinocytosis in macrophages J. Cell Sci. 116 2003 247 257
70. N. Araki, M.T. Johnson, and J.A. Swanson A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages J. Cell Biol. 135 1996 1249 1260
71. H.S. Kruth, N.L. Jones, W. Huang, B. Zhao, I. Ishii, J. Chang, and et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein J. Biol. Chem. 280 2005 2352 2360
72. M.R. Schmidt, T. Maritzen, V. Kukhtina, V.A. Higman, L. Doglio, N.N. Barak, and et al. Regulation of endosomal membrane traffic by a Gadkin/AP-1/kinesin KIF5 complex Proc. Natl. Acad. Sci. U.S.A. 106 2009 15344 15349
73. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem. Biophys. Res. Commun. 353 2007 26 32
74. A. Verma, and F. Stellacci Effect of surface properties on nanoparticle-cell interactions Small 6 2010 12 21
75. C. Tassa, J.L. Duffner, T.A. Lewis, R. Weissleder, S.L. Schreiber, A.N. Koehler, and et al. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles Bioconjugate Chem. 21 2010 14 19
76. K.S. Kawamura, M. Sung, E. Bolewska-Pedyczak, and J. Gariepy Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells Biochemistry 45 2006 1116 1127
77. H. Xia, X. Gao, G. Gu, Z. Liu, Q. Hu, Y. Tu, and et al. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery Int. J. Pharm. 436 2012 840 850
78. H. Wang, Y. Zhao, H. Wang, J. Gong, H. He, M.C. Shin, and et al. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer J. Controlled Release 192 2014 47 56
79. X. Liu, C. Liu, W. Zhang, C. Xie, G. Wei, and W. Lu Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin Int. J. Pharm. 448 2013 159 167
80. J. Chen, S. Li, and Q. Shen Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery Eur. J. Pharm. Sci. 47 2012 430 443
81. R.J. Fields, C.J. Cheng, E. Quijano, C. Weller, N. Kristofik, N. Duong, and et al. Surface modified poly(beta amino ester)-containing nanoparticles for plasmid DNA delivery J. Controlled Release 164 2012 41 48
82. A. Verma, O. Uzun, Y. Hu, H.S. Han, N. Watson, S. Chen, and et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles Nat. Mater. 7 2008 588 595
83. E. Moradi, V. Driton, M. Garnett, F. Falcone, and S. Stolnik Ligand density and clustering effects on endocytosis of folate modified nanoparticles RSC Adv. 2 2012 3025 3033
84. R. Mishra, W. Su, R. Pohmann, J. Pfeuffer, M.G. Sauer, K. Ugurbil, and et al. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding Bioconjugate Chem. 20 2009 1860 1868
85. S. Deshayes, M.C. Morris, G. Divita, and F. Heitz Interactions of amphipathic CPPs with model membranes Biochim. Biophys. Acta 1758 2006 328 335
86. T. Endoh, and T. Ohtsuki Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape Adv. Drug Delivery Rev. 61 2009 704 709
87. F. Duchardt, M. Fotin-Mleczek, H. Schwarz, R. Fischer, and R. Brock A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 8 2007 848 866
88. K.M. Huh, Y.W. Cho, and K. Park PLGA-PEG block copolymers for drug formulations Drug Dev. Delivery 3 2003 5
89. R.K. Averineni, G.V. Shavi, A.K. Gurram, P.B. Deshpande, K. Arumugam, N. Maliyakkal, and et al. PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation Bull. Mater. Sci. 35 2012 319 326
90. S. Marrache, and S. Dhar Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 110 2013 9445 9450
91. S. Manoochehri, B. Darvishi, G. Kamalinia, M. Amini, M. Fallah, S.N. Ostad, and et al. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel Daru 21 2013 58
92. J.C. Munro, and C.W. Frank Adsorption of lipid-functionalized poly(ethylene glycol) to gold surfaces as a cushion for polymer-supported lipid bilayers Langmuir 20 2004 3339 3349
93. D. Li, and R.B. Kaner Shape and aggregation control of nanoparticles: Not shaken, not stirred J. Am. Chem. Soc. 128 2006 968 975
94. G. Kumar, N. Shafiq, and S. Malhotra Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead Crit. Rev. Ther. Drug Carrier Syst. 29 2012 149 182
95. K. Avgoustakis Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Delivery 1 2004 321 333
96. P. Aggarwal, J.B. Hall, C.B. McLeland, M.A. Dobrovolskaia, and S.E. McNeil Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Delivery Rev. 61 2009 428 437
97. E.M. Hotze, T. Phenrat, and G.V. Lowry Nanoparticle aggregation: challenges to understanding transport and reactivity in the environment J. Environ. Qual. 39 2010 1909 1924
98. M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K.A. Dawson Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts Proc. Natl. Acad. Sci. U.S.A. 105 2008 14265 14270
99. C.C. Xiang, F. Yang, M. Li, M. Jaridi, and N.Q. Wu Experimental and statistical analysis of surface charge, aggregation and adsorption behaviors of surface-functionalized titanium dioxide nanoparticles in aquatic system J. Nanoparticle Res. 15 2013 1293
100. J.H. Werth, M. Linsenbuhler, S.M. Dammer, Z. Farkas, H. Hinrichsen, K.E. Wirth, and et al. Agglomeration of charged nanopowders in suspensions Powder Technol. 133 2003 106 112
101. J.H. Werth, S.M. Dammer, Z. Farkas, H. Hinrichsen, and D.E. Wolf Agglomeration in charged suspensions Comput. Phys. Commun. 147 2002 259 262
102. R.P. Bagwe, L.R. Hilliard, and W.H. Tan Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding Langmuir 22 2006 4357 4362